IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Primary Progressive Multiple Sclerosis
Rigshospitalet, Denmarkmonoclonal_antibodyPhase 3Active
B
63/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 89/ 100
Competitive context
23 Active assets in the Primary Progressive Multiple Sclerosis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Ocrevus Indapta Therapeutics, INC. | Phase 4 | BBB |
Fampridine University College Dublin | Phase 4 | BBB |
Fampridine University College Dublin | Phase 4 | BB |
Benadryl Hoffmann-La Roche | Phase 3 | B |
Tolebrutinib Sanofi | Phase 3 | B |
View all 46 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →